Nestle Looks To Cook Up Nutrition Product Sales With Novartis MN Acquisition
This article was originally published in The Tan Sheet
Executive Summary
Nestle looks to become the number two company in the healthcare nutrition field, including the infant formula market, with its planned $2.5 bil. acquisition of Novartis' Medical Nutrition unit
You may also be interested in...
Danone Shakes Up Elderly Care Market With Offer For Medical Nutrition USA
Danone's $62.3 million bid for Medical Nutrition USA will boost the French firm's U.S. nutritional product business, but securities litigators fishing for clients say the deal may shortchange MN shareholders
Novartis/Nestle deal closes
Nestle completed its acquisition of Novartis Medical Nutrition July 1 following "the successful conclusion of the regulatory process," Nestle announces. The Novartis unit and its roughly 2,000 employees will be integrated into Nestle Nutrition, Nestle says. "The acquisition propels Nestle into a strong number two position globally in the fast-growing and lucrative healthcare nutrition market, helping to accelerate the profitable development of the overall nutrition business," the firm adds. Plans for the transaction were announced in December (1"The Tan Sheet" Dec. 18, 2006, p. 8)...
Novartis Cough/Cold OTCs Boost Consumer Health Division In Q1
Novartis' over-the-counter sales achieved double-digit growth in its first quarter on the strength of cough and cold brands and expansion into new markets, particularly Japan, the company said